Jonathan Poole — Chief Financial Officer and Secretary at Genocea Biosciences

Mr. Jonathan Poole has been the Chief Financial Officer of Genocea Biosciences, Inc. since April 2014 and serves as its Secretary. Mr. Poole served as an Investment Manager of Avanti Capital plc. He joined Avanti in April 2004. Prior to joining Genocea, he served as Senior Vice President of Finance for pipeline and technical operations, leading finance support for Shire plc's global business development, R&D and technical operations activities. He served for three years as Divisional Chief Financial Officer of Shire HGT, Shire's $1.5 billion rare disease division. He began his career in the UK in investment banking at UBS Warburg and ING Barings and also served as an Investment Manager for Avanti Capital Plc, a UK private equity investment firm. At ING Barings, he advised small to mid-sized public and private companies on debt and equity financing, M&A and restructurings. He is an Associate Member of the Securities Institute. Mr. Poole has an MBA from London Business School and a BSc in biological sciences from Durham University in the UK.